BioSpace News Archive

Etanercept Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2026s

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

March 24, 2022
·
6 min read
Fluorouracil Market Size, Share, Industry Growth, Trend, Business Opportunities, Challenges, Drivers and Restraint Research Report by 2026

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

March 24, 2022
·
7 min read
Mannitol Injection Market Analysis, Industry Size, Share Leaders, Current Status by Major Key vendors and Trends by Forecast to 2028

The data has been collected through extensive primary and secondary research and is validated by experts in the industry.

March 24, 2022
·
6 min read
FDA

Fresenius Kabi Announces FDA Approval of SMOFlipid® Lipid Injectable Emulsion for Pediatric Patients Requiring Parenteral Nutrition

Fresenius Kabi announced today it has been granted an expanded indication for SMOFlipid® Lipid Injectable Emulsion (ILE) for pediatric patients in the United States, including term and preterm neonates, making it the first and only four-oil lipid emulsion for parenteral nutrition patients of every age.

March 24, 2022
·
6 min read
Cancer Antibody Drug Conjugates Market Patent Insight 2028

Antibody drug conjugates are the unique class of therapeutic agents which consists of three components including monoclonal antibody which targets the antigen, cytotoxic chemotherapeutic agent, and a chemical linker which bridges the two moieties together.

March 24, 2022
·
4 min read
Business

Sosei Heptares Confirms Senior Leadership Changes to Drive the Company Through the Next Stage of its Evolution

Sosei Group Corporation confirms that a series of Executive Management changes have been approved at the Company’s 32nd Shareholders’ Meeting today and are effective immediately.

March 24, 2022
·
8 min read
Business

Innate Pharma Reports Full Year 2021 Financial Results and Business Update

Innate Pharma SA reported its consolidated financial results for the year ending December 31, 2021.

March 24, 2022
·
40 min read
Glycotope Announces New Strategy to Maximize Potential of Uniquely-Tumor Specific Antibody Platform

Glycotope GmbH, a biotechnology company developing antibodies against proteins carrying tumor-specific carbohydrate structures, announces that is has completed a re-focusing of its strategy to better deliver value from its powerful, proprietary glycobiology-informed technology platform.

March 24, 2022
·
4 min read
Pharm Country

Geneos Therapeutics Secures $17 Million in Series A2 Financing to Advance Personalized Cancer Immunotherapy Platform

Geneos Therapeutics, a clinical stage biotherapeutics company focused on the development of tumor neoantigen targeted personalized immunotherapies, announced that it has secured $17 million in Series A2 financing.

March 24, 2022
·
5 min read
The Biomarkers bio-ADM and DPP3 Complement Post-Cardiac Surgery Diagnostics to Early Detect Organ Failure

The diagnostic company SphingoTec GmbH announces new evidence supporting the use of innovative biomarkers in the early identification of organ dysfunction and risk stratification of cardiac surgery patients.

March 24, 2022
·
3 min read